2012
DOI: 10.1016/s0016-5085(12)61496-6
|View full text |Cite
|
Sign up to set email alerts
|

Sa2071 Galectin-9 Induced by Dietary Synbiotics is Involved in Suppression of Allergic Symptoms in Mice and Humans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
12
0
2

Year Published

2012
2012
2018
2018

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(14 citation statements)
references
References 0 publications
0
12
0
2
Order By: Relevance
“…The physiological relevance of in vitro studies with PBMCs is debatable, but several reports have shown that these studies can be predictive for the in vivo situation. de Kivit et al ( 2012 ) reported that increased galectin-9 expression in intestinal epithelial cells and serum induced by dietary symbiotics in mice correlated with reduced acute allergic skin reactions and mast cell degranulation. Parallel studies with stimulation of PBMCs with recombinant galectin-9, showed induction of development of Th1 and Treg cells.…”
Section: Experimental Read Outmentioning
confidence: 99%
“…The physiological relevance of in vitro studies with PBMCs is debatable, but several reports have shown that these studies can be predictive for the in vivo situation. de Kivit et al ( 2012 ) reported that increased galectin-9 expression in intestinal epithelial cells and serum induced by dietary symbiotics in mice correlated with reduced acute allergic skin reactions and mast cell degranulation. Parallel studies with stimulation of PBMCs with recombinant galectin-9, showed induction of development of Th1 and Treg cells.…”
Section: Experimental Read Outmentioning
confidence: 99%
“…In this context, we assume that Gal-9 might be a potent regulator for (auto/ allo)-immune diseases but the murine system might only deliver limited relevance to what happens in human. Interestingly, Gal-9 has been demonstrated to support the suppression of allergic symptoms [58,59] in vivo. At the time of this study, there are 15 active clinical trials running for the MSC-based treatment of autoimmune diseases such as type 1 diabetes, multiple sclerosis, or lupus nephritis, listed at www.clinicaltrials.gov.…”
mentioning
confidence: 99%
“…This increased level was consistent with lowered acute allergic skin reaction and mast cell degranulation. Additionally, this pre-and pro-biotic mixture was demonstrated to augment Th1-and Treg-cell differentiation in lymph nodes and in peripheral blood mononuclear cell cultures exposed to galectin-9 [20].…”
Section: Galectin-9mentioning
confidence: 94%